Cost-Effectiveness of Ranibizumab Versus Photodynamic Therapy for the Treatment of Neovascluar Age-Related Macular Degeneration Based in China Cost Setting
Abstract
Authors
S. Feng X. Ying F. Qi J. Chang
S. Feng X. Ying F. Qi J. Chang
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now